A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
BeOne Medicines
BeOne Medicines
NiKang Therapeutics, Inc.
Regor Pharmaceuticals Inc.
Seagen Inc.
Pliant Therapeutics, Inc.
Eli Lilly and Company
Eli Lilly and Company
Kivu Bioscience Inc.
Mersana Therapeutics
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Fate Therapeutics
Epsilogen Ltd
IDEAYA Biosciences
Cogent Biosciences, Inc.
GlaxoSmithKline
SystImmune Inc.
Institut Paoli-Calmettes
Atavistik Bio, Inc
NiKang Therapeutics, Inc.
Alterome Therapeutics, Inc.
Myeloid Therapeutics
Tizona Therapeutics, Inc
Normunity AccelCo, Inc.
IDEAYA Biosciences
MacroGenics
SystImmune Inc.
M.D. Anderson Cancer Center
Eli Lilly and Company
Shanghai Best-Link Bioscience, LLC
Seagen Inc.
Fusion Pharmaceuticals Inc.
Dren Bio
National Institutes of Health Clinical Center (CC)
Risen (Suzhou) Pharma Tech Co., Ltd.
NextCure, Inc.
NeoTX Therapeutics Ltd.
SystImmune Inc.
NiKang Therapeutics, Inc.
EtiraRx Australia Pty Ltd
Exelixis
Numab Therapeutics AG
Lyell Immunopharma, Inc.
AstraZeneca
NextPoint Therapeutics, Inc.
Eli Lilly and Company
Pfizer
Black Diamond Therapeutics, Inc.
Theratechnologies
Exelixis